Data are available from the NCBI/GEO repository GSE76069 and GSE70941 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=sxghgcmorrulhwr&acc=GSE76069>; <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ulczkewahfmnbov&acc=GSE70941>).

Introduction {#sec001}
============

Studies of behavioral and molecular changes in response to a challenge have exposed the relationship between brain inflammation and incidence of depression-like symptoms \[[@pone.0150858.ref001],[@pone.0150858.ref002]\]. Peripheral infections can alter inflammatory cytokines elicited by microglia, the innate immune cells located in the brain. This alteration of cell signaling dysregulates pathways such as tryptophan metabolism that has been associated with depression-like behaviors. After peripheral challenge with Bacille Calmette-Guérin (BCG) mice display depressive-like behaviors 7 days to 1 month post challenge, well-past sickness recovery. Mice challenged with BCG exhibit sickness symptoms reflected by weight loss early in the first 2 days after challenge compared to control mice challenged with saline followed by recovery of weight by day 5. Recovery from sickness was confirmed by non-significant differences in horizontal locomotor activity and rearing at day 6 post challenge. Despite the recovery from sickness symptoms, depression-like behaviors including significant increase in the duration of immobility measured using the tail suspension test and the Porsolt forced swim test at day 6 and decrease in sucrose ingestion in the sucrose preference test at day 7 were recorded in mice challenged with BCG relative to control mice \[[@pone.0150858.ref003]--[@pone.0150858.ref005]\].

Brain microglia and peripheral macrophages are immune cells yet their response to immune challenge and impact on surrounding cells are different \[[@pone.0150858.ref006]\]. Transcriptome analysis have revealed common and unique profiles among these cell types \[[@pone.0150858.ref007]\]. This suggest that differences between the microglia and macrophage transcriptome could be directly associated with depression-like symptoms. Characterization of the differences between microglia and macrophage transcript isoform abundance, alternative splicing, gene differential expression, and networks after sickness recovery from BCG challenge is essential to understand the role of microglia on depression-like behaviors.

The objective of this study was to uncover the gene expression dysregulation in microglia from mice challenged with BCG that exhibit depression-like symptoms despite having recovered from the associated sickness. This work builds upon our prior study that confirmed in the same mouse populations comparable changes in body weights and other sickness indicators but significant differences in depression-like behaviors between BCG-challenged and Control groups at day 7 post-challenge \[[@pone.0150858.ref005]\]. Analyses supporting the objective of the present study include: 1) uncovering differential gene expression and functional categories between BCG-challenged and Control groups within cell types; 2) uncovering differential gene expression and functional categories between microglia and peripheral macrophages within BCG-challenged group; 3) detection of alternative splicing between microglia and peripheral macrophages in the BCG-challenged group; and 4) network visualization to uncover potential synergistic or antagonistic relationships between BCG-challenge and cell type groups.

Materials and Methods {#sec002}
=====================

Experiments {#sec003}
-----------

All animal care and experimental procedures adhered to NIH guidelines and were approved by the University of Illinois Institutional Animal Care and Use Committee. Measures were taken to minimize the number of animals used and the pain and suffering of the mice.

Microglia and peritoneal macrophages (hereby termed macrophages) were collected from approximately 22 weeks old male C57Bl/6J mice. Mice housing, management, and BCG challenge followed previously described protocols \[[@pone.0150858.ref005],[@pone.0150858.ref008]\]. Briefly, mice were housed individually in standard polypropylene cages including corn cob litter. Housing was under a 12:12 h reversed light/dark cycle (lights on 10:00 PM-10:00 AM) with controlled environmental temperature (23°C) and humidity (45%). Mice were offered water and food (Teklad 8640 chow, Harlan Laboratories, Indianapolis, IN, USA) *ad libitum* and handled daily for one week prior to the trial to ensure adaptation. Mice were acclimated to the light cycle and facility for at least 3 weeks prior to the injection with BCG or saline. All mice were individually handled for a few minutes daily prior to the challenge.

The immune challenge involved live attenuated mycobacteria TICE BCG (50 mg wet weight of lyophilized culture containing 1x10^8^ colony forming units or CFU/vial; Organon Teknika Corp. LLC, USA Inc., USA). Each vial's reconstitution prior to inoculation followed provider instructions using preservative-free saline. No peritoneal mycobacteria infection was reported in mice by day 20 after intraperitoneal infection with BCG; whereas dissemination to other organs, including the spleen, bone marrow, and lung was observed \[[@pone.0150858.ref009]\]. There are no reports of BCG infection of microglia or brain and the peritoneum is a source of non-infected macrophages rather than macrophages from other tissues that could be infected with BCG.

Individual mice were challenged once with either 10 mg/mouse (BCG-challenged group, n = 12) or sterile saline solution (Control group, n = 12) administered via intraperitoneal injection \[[@pone.0150858.ref005]\]. No mouse became severely ill or died at any time prior to the experimental endpoint. Mice were euthanized by CO~2~ asphyxiation by trained personnel 7 days after BCG challenge and all efforts were made to minimize suffering. The endpoint was selected based on prior work that demonstrated the recovery from sickness yet persistence of depressive-like symptoms 7 days after challenge \[[@pone.0150858.ref005]\].

Macrophages were collected from peritoneal tissue using the proven protocols \[[@pone.0150858.ref008],[@pone.0150858.ref010]\]. Abdomens were disinfected, skin was retracted, and the peritoneal cavity was flushed with Hank\'s Balanced Salt Solution (cold harvest medium). The peritoneal fluid was centrifuged and the resulting cell pellet was resuspended and plated. The medium was aspired after 2 h incubation to remove non-adherent cells. The surviving adherent cells constituted the non-thioglycollate elicited peritoneal macrophages and cells from individual mice were stored in Trizol at -80°C until RNA extraction \[[@pone.0150858.ref011]\].

After peritoneum collection (\~5 minutes), mice were perfused, and the brains were excised and minced. Microglia were collected following established protocols \[[@pone.0150858.ref012]\]. In brief, brains were trypsinized \[[@pone.0150858.ref013]\], dissociated using cell screens (40 μm), centrifuged, resuspended in 30% Percoll (GE Healthcare, Princeton, NJ), then centrifuged for myelin removal. Brain cells were labeled with anti-CD11b (integrin alpha M antibody) magnetized Miltenyi MicroBeads (Miltenyi Biotec, Germany). Cells were separated in a magnetic field with MS columns (Miltenyi Biotec, Germany). The resulting Cd11b^+^ fraction collected was centrifuged, resuspended, and stored at -80°C. Flow cytometry validation of cell isolation encompassed cell staining with primary fluorescent antibodies for two primary markers for macrophages and microglia: CD11b and CD45 (protein tyrosine phosphatase, receptor type, C antibody) \[[@pone.0150858.ref014],[@pone.0150858.ref015]\]. Fc receptors were blocked by incubation with anti-CD16/CD32 antibody before incubation with eBioscience anti-CD11b and anti-CD45 antibodies (eBioscience Inc., San Diego, CA). Surface receptor expression was identified using a Biosciences LSR II Flow Cytometry Analyzer with BD FACSDiva software (BD Biosciences, San Jose, CA). Antibody gating was determined using isotype-stained controls. Cells were \~93% Cd11b^+^ and \~91% Cd45^+^, confirming microglia enrichment.

RNA extraction from microglia followed the Tripsin method using a total RNA Kit (Omega Biotek, Norcross, GA) and a DNase step to remove DNA contamination \[[@pone.0150858.ref011]\]. The Agilent 2100 Bioanalyzer with RNA Pico chip (Agilent Technologies, Palo Alto, CA) was used to assess RNA Integrity Numbers. RNA Integrity Numbers were \> 9 in 90% of the samples and \> 7 in 100% of the 48 samples.

Identification of differential transcript isoform and gene expression {#sec004}
---------------------------------------------------------------------

RNA libraries from individual mouse were sequenced using an Illumina HiSeq 2000 (Illumina, San Diego, CA) and 100nt long paired-end reads were obtained. Read quality control was implemented using FastQC \[[@pone.0150858.ref008],[@pone.0150858.ref016]\]. Quality control analysis indicated that the Phred nucleotide quality score was \> 30 across the length of the reads such that the read sequences were not trimmed.

Reads were mapped to the Genome Reference Consortium GRCm38 mouse assembly using Tophat2 (v 2.0.8) \[[@pone.0150858.ref017]\] with the Illumina iGenomes package (mm10; <http://support.illumina.com/sequencing/sequencing_software/igenome.html>). Reads were combined into transcripts and differential expression was tested using Cufflinks (v2.1.1) \[[@pone.0150858.ref018]\]. The specifications beyond the default settings used to obtain transcript abundance levels were: a) Upper Quartile Normalization was used to normalize the median transcript counts across libraries; b) multi-read correction for reads mapping to multiple sites; and c) fragment bias correction \[[@pone.0150858.ref019]\]. Four comparisons were evaluated: two pairwise contrasts between BGG-challenge groups within cell types, and two pairwise contrasts between cells within BCG-challenge groups. Results from genes with at least 10 mapped reads were considered. Multiple test adjustment used the Benjamini-Hoechberg false discovery rate (FDR) approach \[[@pone.0150858.ref020],[@pone.0150858.ref021]\]. Genes exhibiting an FDR-adjusted P-value \< 0.05 were considered differentially expressed.

Identification of alternative splicing events {#sec005}
---------------------------------------------

Alternative splicing events characterizing differences between groups (i.e., cell types or challenge level) were identified using a quantitative approach \[[@pone.0150858.ref022]\]. Quantitative characterization considered genes detected in both groups, represented by at least two transcript isoforms, and with at least one transcript isoform differentially expressed between groups (FDR-adjusted P-value \< 0.05) between groups in one direction (over- or under-expressed) and the rest of the isoforms not differentially expressed or differentially expressed in the other direction.

Identification of functional categories over-represented among gene profiles {#sec006}
----------------------------------------------------------------------------

Functional analyses of the transcript isoforms differentially expressed between BCG-challenge groups within cell types, between cell types within BCG-challenged groups, and of transcript isoforms expressed exclusively in one cell type were performed using hypergeometric testing and Gene Set Enrichment Analysis (GSEA). These analyses allowed the identification of Gene Ontology (<http://www.geneontology.org/>) biological processes, molecular functions, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways (<http://www.genome.jp/org/>). The hypergeometric test was implemented in the Database for Annotation, Visualization and Integrated Discovery (DAVID, <http://david.abcc.ncifcrf.gov>) \[[@pone.0150858.ref023],[@pone.0150858.ref024]\]. Gene Ontology (GO) results were reported using the DAVID Functional Annotation Tool (FAT) classes to facilitate interpretation. Category enrichment was measured using Expression Analysis Systematic Explorer (EASE) scores computed based on a one-tailed jackknifed Fisher exact test \[[@pone.0150858.ref025],[@pone.0150858.ref026]\]. The GO categories were clustered and the statistical significance of each cluster was assessed using an Enrichment Score (-log~10~ geometric mean of the cluster members EASE scores \[[@pone.0150858.ref027],[@pone.0150858.ref028]\]. Functional annotation clusters were considered significant at Enrichment Score \> 2 (comparable to P-value \< 0.001) using the *Mus musculus* genome as background. Gene Set Enrichment Analysis was implemented using the GSEA-P software package \[[@pone.0150858.ref029],[@pone.0150858.ref030]\]. This approach offered functional insights complementary to DAVID based on the consideration of the expression profile of all the genes analyzed and annotations to the Molecular Signature Database (MSigDB) \[[@pone.0150858.ref031]\].

Gene network visualization {#sec007}
--------------------------

Interpretation of findings and discovery of differences in gene co-expression associated with BCG challenge or cell type were enhanced using network visualization. Networks were visualized using the BisoGenet plug-in \[[@pone.0150858.ref027],[@pone.0150858.ref028],[@pone.0150858.ref032]\] within the Cytoscape environment \[[@pone.0150858.ref024],[@pone.0150858.ref033]\]. BisoGenet enabled the visualization of associations between genes detected in the present study using information from the SysBiomics repository. Networks depicting genes as nodes and gene associations as edges and including at most one non-measured gene connecting observed genes were considered. The resulting gene networks were augmented with information on differential gene expression results from the comparison between BCG-challenged and cell type groups obtained in this study. The node size represented the differential expression P-value and the node color denoted over- or under-expression between challenge levels or cell types.

Results and Discussion {#sec008}
======================

Global transcriptome profiles across immune challenge groups and cell types {#sec009}
---------------------------------------------------------------------------

Among more than 15,000 genes tested, 562 and 3,851 were differentially expressed (FDR-adjusted P-value \< 0.05) between the BCG-challenged and Control groups in microglia and macrophages, respectively ([Table 1](#pone.0150858.t001){ref-type="table"}). Differential abundance of transcript isoforms between BCG-challenged groups followed similar patterns *albeit* at lower absolute count number. Significant gene expression differences between cell types were more prevalent and extreme than between BCG-challenged groups. Approximately 9,117 genes (9,780 transcript isoforms) were differentially expressed between microglia and macrophages in the BCG-challenged group. Among these, 6,590 genes (8,144 transcripts) overlapped between cell types across BCG-challenged groups. The prevalent differential expression between cell types is consistent with prior transcriptomic comparisons and has been linked to differences in cell type origin and local environment \[[@pone.0150858.ref007],[@pone.0150858.ref034],[@pone.0150858.ref035]\].

10.1371/journal.pone.0150858.t001

###### Number of genes and transcript isoforms analyzed and differentially expressed between BCG-challenged (BCG) and Control mice within cell type and between microglia and macrophages within challenge group and overlapping counts.
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  Comparison                         Genes    Transcript isoforms                           
  ---------------------------------- -------- --------------------- ----- -------- -------- -----
  Microglia Control vs. BCG          15,293   562                   18    39,005   317      6
  Macrophages Control vs. BCG        13,245   3,851                 286   32,743   2,381    160
  Overlap                                     353                                  245      
  Control Microglia vs Macrophages   15,287   9,860                 0     29,110   11,113   0
  BCG Microglia vs. Macrophages      15,828   9,117                 890   42,035   9,780    735
  Overlap                                     6,590                                8,144    
  Unique to Macrophages Control               23                                   42       
  Unique to Microglia Control                 236                                  421      
  Unique to Macrophages BCG                   3                                    20       
  Unique to Microglia BCG                     214                                  300      

DE^1^: differentially expressed genes or transcript isoforms (FDR-adjusted P-value \< 0.05) or uniquely detected in either cell type.

Differences in the microglia transcriptome between BCG-challenged and Control mice {#sec010}
----------------------------------------------------------------------------------

Differential gene and transcript isoform expression in microglia between BCG-challenged and Control mice are presented in [Table 1](#pone.0150858.t001){ref-type="table"}. Among the differentially expressed genes in the microglia, 518 genes were over-expressed whereas only 44 genes were under-expressed in the BCG-challenged relative to Control mice. The predominance of over-expressed genes (92%) in response to BCG-challenge is consistent with previous reports of transcriptome changes in the microglia in response to lipopolysaccharide (LPS) challenge \[[@pone.0150858.ref036]\]. Differentially expressed genes between BCG-challenged and Control in microglia ((\|log~2~(fold change)\| \> 3, FDR-adjusted P-value \< 2.0 x 10^−3^) are listed in [Table 2](#pone.0150858.t002){ref-type="table"} together with supporting literature. An extended list of differentially expressed genes in microglia is provided in [S1 Table](#pone.0150858.s001){ref-type="supplementary-material"}.

10.1371/journal.pone.0150858.t002

###### Most extreme differentially expressed genes between BCG-challenged and Control mice within microglia (\|log~2~(fold change)\| \> 3, FDR-adjusted P-value \< 2.0 x 10^−3^) and macrophages (\|log~2~(fold change)\| \> 6, FDR-adjusted P-value \< 3.0 x 10^−4^) and supporting literature review.
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  Gene Symbol                                   Gene name NCBI                                                                         Log~2~(BCG/ Control)   References
  --------------------------------------------- -------------------------------------------------------------------------------------- ---------------------- -------------------------------------------------------------------------------------------------
  Microglia; BCG-challenged vs Control mice                                                                                                                   
  Saa3                                          serum amyloid A 3                                                                      5.90                   \[[@pone.0150858.ref037]--[@pone.0150858.ref040]\]
  Cadm3                                         cell adhesion molecule 3                                                               5.14                   \[[@pone.0150858.ref037]\]
  Steap4                                        STEAP family member 4                                                                  4.89                   \[[@pone.0150858.ref041],[@pone.0150858.ref042]\]
  Sele                                          selectin E                                                                             4.80                   \[[@pone.0150858.ref043],[@pone.0150858.ref044]\]
  Cxcr1                                         chemokine (C-X-C Motif) receptor 1                                                     4.03                   \[[@pone.0150858.ref039],[@pone.0150858.ref045],[@pone.0150858.ref046]\]
  Ifitm1                                        interferon induced transmembrane protein 1                                             3.72                   \[[@pone.0150858.ref038],[@pone.0150858.ref039],[@pone.0150858.ref044],[@pone.0150858.ref047]\]
  Irg1                                          immunoresponsive 1 homolog: involved in the inhibition of the inflammatory response.   3.66                   \[[@pone.0150858.ref046],[@pone.0150858.ref048],[@pone.0150858.ref049]\]
  Lrg1                                          leucine-rich alpha-2-glycoprotein 1                                                    3.57                   \[[@pone.0150858.ref040],[@pone.0150858.ref050]\]
  Prok2                                         prokineticin 2                                                                         3.48                   \[[@pone.0150858.ref050]\]
  Cfb                                           complement factor B                                                                    3.39                   \[[@pone.0150858.ref038]\]
  Slfn4                                         schlafen 4                                                                             3.33                   \[[@pone.0150858.ref040],[@pone.0150858.ref048]\]
  Nxpe5                                         neurexophilin and PC-esterase domain family, member 5                                  3.29                   \[[@pone.0150858.ref051]\]
  Ly6i                                          lymphocyte antigen 6 complex, locus I                                                  3.29                   \[[@pone.0150858.ref038],[@pone.0150858.ref049]\]
  Oas3                                          2\'-5\'-oligoadenylate synthetase 3, 100kDa                                            3.27                   \[[@pone.0150858.ref038],[@pone.0150858.ref052]\]
  Ifi205                                        interferon activated gene 205                                                          3.15                   \[[@pone.0150858.ref038],[@pone.0150858.ref053]\]
  Stfa1                                         stefin A1                                                                              3.12                   \[[@pone.0150858.ref054]\]
  Plac8                                         placenta-specific 8                                                                    3.09                   \[[@pone.0150858.ref038],[@pone.0150858.ref044]\]
  Macrophages; BCG-challenged vs Control mice                                                                                                                 
  S100a9                                        S100 calcium binding protein A9 (calgranulin B)                                        10.11                  \[[@pone.0150858.ref055]\]
  Mrgpra2a                                      MAS-related GPR, member A2A                                                            10.10                  
  Ly6i                                          lymphocyte antigen 6 complex, locus I                                                  9.42                   
  Asprv1                                        aspartic peptidase, retroviral-like 1                                                  9.15                   
  Ly6c2                                         lymphocyte antigen 6 complex, locus C2                                                 7.92                   \[[@pone.0150858.ref056]\]
  Nos2                                          nitric oxide synthase 2, inducible                                                     7.69                   \[[@pone.0150858.ref057]\]
  Il1f9                                         interleukin 1 family, member 9                                                         7.66                   \[[@pone.0150858.ref058]\]
  Ccl8                                          chemokine (C-C motif) ligand 8                                                         7.45                   \[[@pone.0150858.ref041]\]
  2010002M12Rik                                 interferon induced protein with tetratricopeptide repeats 1B like 2                    7.32                   
  Spon1                                         spondin 1, (f-spondin) extracellular matrix protein                                    7.23                   \[[@pone.0150858.ref059]\]
  S100a8                                        S100 calcium binding protein A8 (calgranulin A)                                        7.15                   \[[@pone.0150858.ref060]\]
  Cxcr2                                         chemokine (C-X-C motif) receptor 2                                                     7.02                   
  Ifng                                          interferon gamma                                                                       6.45                   \[[@pone.0150858.ref061]\]
  Cxcl9                                         chemokine (C-X-C motif) ligand 9                                                       6.40                   
  Gpr141                                        G protein-coupled receptor 141                                                         6.15                   
  2010005H15Rik                                 RIKEN cDNA 2010005H15 gene                                                             6.14                   
  Iigp1                                         interferon inducible GTPase 1                                                          6.08                   

Studies of behavioral and molecular changes in response to BCG challenge have exposed the relationship between brain inflammation and incidence of depression-like symptoms \[[@pone.0150858.ref001],[@pone.0150858.ref002]\]. These studies have reported increased levels of inflammatory cytokines expression in the microglia. Similarly, the present study detected over-expression of genes related to inflammatory response 7 days after challenge ([Table 2](#pone.0150858.t002){ref-type="table"}, [S1 Table](#pone.0150858.s001){ref-type="supplementary-material"}) including Serum amyloid A3 (Saa3), S100 calcium binding protein A8 (S100a8), S100 calcium binding protein A9 (S100a9), Fc-gamma receptors (Fcgr4 and Fcgr2b), prostaglandin-endoperoxide synthase 2 (Ptgs2), interleukin 1beta (Il1b), and interleukins receptors (Il1r1 and Il4ra).

Consistent with our findings, an immune challenge event can elicit over-expression of Saa3 in the brain. Also, the levels of Saa3 in microglia increase in response to mouse hepatitis virus-JHM \[[@pone.0150858.ref062]\] and a strain of Creutzfeldt-Jakob disease \[[@pone.0150858.ref063]\]. The expression of Saa3 could be induced by S100A8 and S100A9 and these were over-expressed as well. Altered expression of S100A9 has been reported in neurological diseases associated with inflammation and depression such as cerebral ischemia, traumatic brain injury, and Alzheimer's disease \[[@pone.0150858.ref064],[@pone.0150858.ref065]\].

Fc receptors are expressed in immune cells and connect humoral and cell-mediated response to pathogen infection \[[@pone.0150858.ref066]\]. Polymorphism in these receptors were associated with susceptibility to Guillain-Barré syndrome and multiple sclerosis, disorders that exhibit depression symptoms \[[@pone.0150858.ref067]\]. Increased levels of Fcgr4 and Fcgr2b expression, similar to that observed in this study, induce vascular damage and exacerbate neurodegenerative conditions in humans \[[@pone.0150858.ref068]\]. Activation of microglia through Fc gamma receptors results in phagocytosis and polarization to an M2b phenotype \[[@pone.0150858.ref068]\] and similarly, Fc receptor overexpression was correlated with over-expressed pro-inflammatory cytokines in the present and previous studies \[[@pone.0150858.ref069],[@pone.0150858.ref070]\]. Similarly, Ptgs2 was over-expressed in the microglia in our study and has been related to inflammatory response in the brain and to neurodegeneration processes \[[@pone.0150858.ref071]\]. This gene has been proposed as a therapeutic target for neurodegenerative diseases that encompass depressive behaviors such as Parkinson, Alzheimer, and Huntington's disease \[[@pone.0150858.ref072]\].

Over-expression of pro-inflammatory cytokines such as interleukin Il1b has been linked to neurodegenerative disorders such as Alzheimer's disease \[[@pone.0150858.ref065],[@pone.0150858.ref073]\]. Il1b has been linked to depressive behaviors \[[@pone.0150858.ref074],[@pone.0150858.ref075]\] and therapies blocking Il1b expression in a mouse model of Alzheimer's disease decreased the synthesis of S100 proteins, decreased fibrillar deposition, and protected mice from cognitive deficits \[[@pone.0150858.ref076]\]. Our transcriptome findings in the microglia are consistent with reports that mice express depression-like behaviors 7 days after of inoculation with BCG \[[@pone.0150858.ref005],[@pone.0150858.ref077]\].

Differences in the macrophage transcriptome between BCG-challenged and Control mice {#sec011}
-----------------------------------------------------------------------------------

The comparison of gene expression profiles in macrophages between BCG-challenged and Control mice enabled us to uncover changes common to macrophage and microglia immune cells and changes unique to microglia cells. Differential gene and transcript isoform expression between BCG-challenged and Control mice in macrophages are listed in [Table 1](#pone.0150858.t001){ref-type="table"}. Among the 3,851 differentially expressed genes in macrophages, 2,151 were over-expressed and 1,700 were under-expressed in the BCG-challenged relative to Control mice. The predominance of over-expressed genes (75%) in response to BCG-challenge is consistent with previous reports of transcriptome changes in the macrophages in response to BCG challenge \[[@pone.0150858.ref078]\] and consistent with the microglia changes previously described. Among these genes S100A9, S100A8, Il1b, interferon gamma (Ifng), nitric oxide synthase 2 inducible (Nos2), and interleukin 1 family member 9 (Il1f9) were identified. Like in microglia, many differentially expressed genes in macrophages were related with inflammatory response. Differentially expressed genes between BCG-challenged and Control in macrophages (\|log~2~(fold change)\| \> 6, FDR-adjusted P-value \< 3.0 x 10^−4^) are listed in [Table 2](#pone.0150858.t002){ref-type="table"} together with supporting literature. An extended list of differentially expressed genes in macrophages is provided in [S1 Table](#pone.0150858.s001){ref-type="supplementary-material"}.

The increase in expression of Ifng and Nos2 is a component in the macrophage response to infectious or inflammatory diseases represented in our study by the BCG challenge \[[@pone.0150858.ref061],[@pone.0150858.ref079]\]. High levels of Ifng were found in patients diagnosed with major depression without pathogen stimuli \[[@pone.0150858.ref080]--[@pone.0150858.ref084]\]. Additionally, an increase in Ifng expression up-regulates Caspase 1 (Casp1), an enzyme that converts pro-Il1b into active mature Il1b \[[@pone.0150858.ref085]\] and that has a role in acute \[[@pone.0150858.ref086]\] and major depression \[[@pone.0150858.ref074],[@pone.0150858.ref075]\]. Our results corroborated that the up-regulation of Ifng and Il1b ([Table 2](#pone.0150858.t002){ref-type="table"}, [S1 Table](#pone.0150858.s001){ref-type="supplementary-material"}) is correlated with the development of depression-like behavior in BCG-challenged mice \[[@pone.0150858.ref005],[@pone.0150858.ref077]\].

Transcriptome differences between BCG-challenged and Control mice shared between cell types {#sec012}
-------------------------------------------------------------------------------------------

Among the genes differentially expressed between BCG-challenged and Control mice, 353 genes overlapped between microglia and macrophages ([Table 1](#pone.0150858.t001){ref-type="table"}). Shared profiles were identified in genes belonging to families involved in immune response including: S100A8, S100A9, Il1r1, and Il1b. Kynurenine 3-monooxygenase (Kmo) was over-expressed (FDR-adjusted P-value \< 0.05) in BCG-challenged relative to Control mice, both in microglia and macrophages ([S1 Table](#pone.0150858.s001){ref-type="supplementary-material"}). Kmo catalyzes the conversion of kynurenine to 3-hydroxykynurenine and modulation of KMO activity has been implicated in several neurodegenerative diseases \[[@pone.0150858.ref087]\]. Over-expression of Il1b and Kmo was observed in the microglia of mice that also exhibited social withdrawal after LPS injection \[[@pone.0150858.ref088]\]. Also, over-expression of Kmo was reported in the rat whole brain after a systemic challenge with LPS \[[@pone.0150858.ref089],[@pone.0150858.ref090]\] and in human brain cells after Il1b treatment \[[@pone.0150858.ref091]\]. On the other hand, a study of mouse whole brain after BCG-challenge reported over-expression of indoleamine 2,3-dioxygenase 1 (Ido1) but no differential expression of Kmo \[[@pone.0150858.ref092]\]. Both, Kmo and Ido1 reduce the level of circulating tryptophan and production of serotonin and increase the levels of tryptophan metabolites that have cytotoxic effect \[[@pone.0150858.ref001],[@pone.0150858.ref002]\]. In the present study, Kmo was over-expressed but Ido1 and the ortholog Ido2 were not differentially expressed in the microglia between BCG-challenged and Control mice. Our study supports the emerging notion that Kmo could be induced by immune challenge \[[@pone.0150858.ref093],[@pone.0150858.ref094]\] and, as potential target of inflammatory cytokines in the kynurenine pathway, Kmo could be associated with behavioral disorders.

Functional analysis of microglia and macrophages transcriptomic differences between BCG-challenged and Control mice {#sec013}
-------------------------------------------------------------------------------------------------------------------

Analysis of enriched functional categories based on the comparison of genes expression profiles between BCG-challenged and Control mice in microglia and macrophages offered insights into the biological processes and pathways associated with BCG-challenge. [Table 3](#pone.0150858.t003){ref-type="table"} summarizes the clusters of functional categories surpassing a DAVID Enrichment Score \> 4. [S2 Table](#pone.0150858.s002){ref-type="supplementary-material"} presents the complete list of categories that exhibited an Enrichment Score \> 2 and corresponding gene count.

10.1371/journal.pone.0150858.t003

###### Most significant clusters (DAVID Enrichment Score ES \> 4) of enriched Gene Ontology (GO) biological processes (BP) and molecular functions (MF) among the genes differentially abundant between BCG-challenged and Control mice within cell type.
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  Cell type and cluster[^1^](#t003fn001){ref-type="table-fn"}   Terms[^2^](#t003fn002){ref-type="table-fn"}                                                                                                                                        ES
  ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------
  Microglia                                                                                                                                                                                                                                        
  BP                                                            \~defense response \~inflammatory response \~response to wounding                                                                                                                  12.96
  BP                                                            \~chemotaxis \~taxis \~locomotory behavior                                                                                                                                         5.63
  MF                                                            \~carbohydrate binding \~polysaccharide binding \~pattern binding                                                                                                                  5.12
  MF                                                            \~peptidase inhibitor activity \~endopeptidase inhibitor activity \~enzyme inhibitor activity                                                                                      4.88
  BP                                                            \~immune effector process \~adaptive immune response \~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains   4.75
  BP                                                            \~cell adhesion \~biological adhesion \~cell-cell adhesion                                                                                                                         4.37
  Macrophages                                                                                                                                                                                                                                      
  BP                                                            \~defense response \~response to wounding \~inflammatory response                                                                                                                  13.32
  MF                                                            \~carbohydrate binding \~polysaccharide binding \~pattern binding                                                                                                                  8.18
  BP,MF                                                         \~chemotaxis \~taxis \~chemokine activity                                                                                                                                          7.79
  BP                                                            \~cell activation \~leukocyte activation \~lymphocyte activation                                                                                                                   6.17
  BP                                                            \~vasculature development \~blood vessel development \~blood vessel morphogenesis                                                                                                  6.12
  BP                                                            \~regulation of cytokine production \~positive regulation of cytokine production \~positive regulation of multicellular organismal process                                         5.97
  BP                                                            \~positive regulation of immune system process \~positive regulation of response to stimulus \~positive regulation of immune response                                              5.86
  BP                                                            \~immune effector process \~leukocyte mediated immunity \~adaptive immune response                                                                                                 5.02
  BP                                                            \~apoptosis \~programmed cell death \~cell death                                                                                                                                   4.77
  BP                                                            \~regulation of phosphorylation \~regulation of phosphorus metabolic process \~regulation of phosphate metabolic process                                                           4.34
  BP,MF                                                         \~GTPase regulator activity \~nucleoside-triphosphatase regulator activity \~GTPase activator activity                                                                             4.20
  BP                                                            \~positive regulation of immune system process \~regulation of leukocyte activation \~regulation of cell activation                                                                4.01

^1^ Each row corresponds to a cluster of Functional Annotation Tool (FAT) GO categories.

^2^ The three GO terms exhibiting most significant enrichment P-value in each cluster are listed, separated by "\~". Additional information in each cluster is provided in [S2 Table](#pone.0150858.s002){ref-type="supplementary-material"}.

Enriched functional categories shared by both cell types included immunological response, chemotaxis, cell migration and apoptosis among others biological processes and molecular functions ([Table 3](#pone.0150858.t003){ref-type="table"}, [S2 Table](#pone.0150858.s002){ref-type="supplementary-material"}). These clusters with highest enrichment overlap between microglia and macrophages, corroborating the persistence of systemic response 7 days after BCG-challenge. The enrichment of apoptosis-related processes observed in this and previous studies \[[@pone.0150858.ref095]\] is associated with the over-expression of Nos2 in both cell types ([Table 2](#pone.0150858.t002){ref-type="table"}). Likewise, the enrichment of monocyte and leukocyte migration processes ([Table 3](#pone.0150858.t003){ref-type="table"}) reported here and by others \[[@pone.0150858.ref096]\] is in correspondence with the over-expression of S100A9 and S100A8 ([Table 2](#pone.0150858.t002){ref-type="table"}) in both cell types. Higher leukocyte migration, activity of the pro-inflammatory cytokines \[[@pone.0150858.ref097]\], and apoptosis \[[@pone.0150858.ref098]\] were all observed in patients with major depression disorders. Additionally, the observed enrichment of protein metabolism including inhibition of enzymes and peptidases is compatible to changes in protein metabolism and downregulation of proteolysis reported in patients with bipolar depression \[[@pone.0150858.ref099],[@pone.0150858.ref100]\] and schizophrenia \[[@pone.0150858.ref101]\].

Complementary functional analysis of the microglia and macrophages profiles using GSEA (Tables [4](#pone.0150858.t004){ref-type="table"} and [5](#pone.0150858.t005){ref-type="table"}, respectively) confirmed the previous gene list enrichment and further enabled the discrimination of enrichment among over- and under-expressed genes in BCG-challenged relative to Control mice. [S3](#pone.0150858.s003){ref-type="supplementary-material"} and [S4](#pone.0150858.s004){ref-type="supplementary-material"} Tables include additional categories enriched at P-value \< 0.05 and with a minimum of 10 genes in microglia and macrophages, respectively. A remarkable GSEA finding in microglia was the downregulation of inositol metabolism because this result is consistent with changes in this metabolite in schizophrenia, bipolar, and depression disorders \[[@pone.0150858.ref101],[@pone.0150858.ref102]\].

10.1371/journal.pone.0150858.t004

###### Gene Set Enrichment Analysis (GSEA) categories enriched among transcript isoforms over-expressed (FDR-adjusted P-value \< 5.0 x 10^−4^ \> 10 transcript isoforms) and under-expressed (P-value \< 0.05 \> 10 transcript isoforms) in BCG-challenged relative to Control mice in microglia.
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  Categories                                          NG[^1^](#t004fn001){ref-type="table-fn"}   P-value     FDR [^2^](#t004fn002){ref-type="table-fn"}
  --------------------------------------------------- ------------------------------------------ ----------- --------------------------------------------
  Over-expressed in BCG-challenged vs Control mice                                                           
  Defense response                                    147                                        \<0.1E-05   \<0.1E-05
  Inflammatory response                               79                                         \<0.1E-05   \<0.1E-05
  Response to other organism                          41                                         \<0.1E-05   \<0.1E-05
  Immune response                                     152                                        \<0.1E-05   \<0.1E-05
  Response to virus                                   31                                         \<0.1E-05   \<0.1E-05
  Response to external stimulus                       183                                        \<0.1E-05   \<0.1E-05
  Immune system process                               219                                        \<0.1E-05   \<0.1E-05
  Response to wounding                                113                                        \<0.1E-05   \<0.1E-05
  KEGG cytokine cytokine receptor interaction         146                                        \<0.1E-05   \<0.1E-05
  Multi organism process                              77                                         \<0.1E-05   \<0.1E-05
  Response to biotic stimulus                         69                                         \<0.1E-05   \<0.1E-05
  Locomotory behavior                                 57                                         \<0.1E-05   7.98E-05
  Cation homeostasis                                  58                                         \<0.1E-05   8.65E-05
  Cellular cation homeostasis                         56                                         \<0.1E-05   1.49E-04
  G protein coupled receptor binding                  30                                         \<0.1E-05   2.80E-04
  Ion homeostasis                                     65                                         \<0.1E-05   3.30E-04
  Under-expressed in BCG-challenged vs Control mice                                                          
  Nervous system development                          228                                        \<0.1E-05   1.00E+00
  Polysaccharide binding                              19                                         2.85E-03    7.91E-01
  Glycosaminoglycan binding                           18                                         5.46E-03    5.51E-01
  KEGG inositol phosphate metabolism                  42                                         8.10E-03    7.12E-01
  Central nervous system development                  73                                         1.24E-02    9.92E-01
  Protein secretion                                   16                                         1.43E-02    6.71E-01
  Transmission of nerve impulse                       85                                         2.27E-02    6.72E-01
  KEGG Parkinson's disease                            94                                         3.03E-02    7.31E-01
  Cellular protein complex assembly                   30                                         4.28E-02    1.00E+00
  Synaptic transmission                               75                                         4.76E-02    8.86E-01

^1^ NG: number of genes.

^2^ FDR: adjusted P-value.

10.1371/journal.pone.0150858.t005

###### Gene Set Enrichment Analysis (GSEA) categories enriched among transcript isoforms over-expressed (FDR-adjusted P-value \< 1.5 x 10^−2^ \> 10 transcript isoforms) and under- expressed (FDR-adjusted P-value \< 5 x 10^−4^ \> 10 transcript isoforms) in BCG-challenged relative to Control mice in macrophages.

![](pone.0150858.t005){#pone.0150858.t005g}

  Categories                                                   NG[^1^](#t005fn001){ref-type="table-fn"}   P-value     FDR[^2^](#t005fn002){ref-type="table-fn"}
  ------------------------------------------------------------ ------------------------------------------ ----------- -------------------------------------------
  Over-expressed in BCG-challenged relative to Control mice                                                           
  KEGG ECM receptor interaction                                45                                         \<0.1E-05   9.96E-04
  Defense response                                             144                                        \<0.1E-05   5.88E-03
  Inflammatory response                                        73                                         \<0.1E-05   1.28E-02
  Serine type peptidase activity                               18                                         \<0.1E-05   1.31E-02
  Serine hydrolase activity                                    19                                         \<0.1E-05   1.32E-02
  KEGG proteasome                                              43                                         \<0.1E-05   1.48E-02
  Under-expressed in BCG-challenged relative to Control mice                                                          
  KEGG ribosome                                                78                                         \<0.1E-05   \<0.1E-05
  Structural constituent of ribosome                           75                                         \<0.1E-05   \<0.1E-05
  Gated channel activity                                       27                                         \<0.1E-05   \<0.1E-05
  Cation channel activity                                      29                                         \<0.1E-05   2.39E-04

^1^ NG: number of genes.

^2^ FDR: adjusted P-value.

Gene networks of microglia and macrophages transcriptomic differences between BCG-challenged and Control mice {#sec014}
-------------------------------------------------------------------------------------------------------------

Visualization of networks of genes differentially expressed between BCG-challenged and Control mice in microglia ([Fig 1](#pone.0150858.g001){ref-type="fig"}) and macrophages ([Fig 2](#pone.0150858.g002){ref-type="fig"}) augmented our understanding of the molecular relationships among genes. Networks including more than 5 connected genes are discussed. The predominance of over-expressed genes relative to under-expressed genes in both networks is in agreement with their predominance among the most differentially expressed genes in [Table 2](#pone.0150858.t002){ref-type="table"} and with the enriched categories detected using GSEA (Tables [4](#pone.0150858.t004){ref-type="table"} and [5](#pone.0150858.t005){ref-type="table"}). These networks also exhibit a predominance of genes related to immune response.

![Network of genes differentially expressed between BCG-challenged and Control mice in microglia.\
Red (green) nodes denote genes over- (under-) expressed in BCG-challenged relative to Control mice. Node size represents the P-value were larger nodes indicates more extreme significance (FDR-adjusted P-value \< 0.001 larger nodes; P-value \< 0.05 intermediate nodes; P-value \< 0.1 small nodes). Edges denote known relationships between genes in the SysBiomics repository. Framed genes (squares) are discussed in the manuscript.](pone.0150858.g001){#pone.0150858.g001}

![Network of genes differentially expressed between BCG-challenged and Control mice in macrophages.\
Red (green) nodes denote genes over- (under-) expressed in BCG-challenged relative to Control mice. All genes were differentially expressed at FDR-adjusted P-value \< 0.001. Edges denote known relationships between genes in the SysBiomics repository. Framed genes (squares) are discussed in the manuscript.](pone.0150858.g002){#pone.0150858.g002}

The microglia network ([Fig 1](#pone.0150858.g001){ref-type="fig"}) includes 57 gene nodes and 84% of the genes were over-expressed in BCG-challenged relative to Control (most at FDR-adjusted P-value \< 0.001). In this network, Janus kinase 2 (Jak2), signal transducer and activator of transcription 3 (Stat3), signal transducer and activator of transcription 1 (Stat1), and nuclear factor erythroid derived 2 (Nfe2) were well-connected gene nodes linking to 11, 7, 5, and 5 other gene nodes, respectively. These genes were over-expressed in BCG-challenge relative to Control mice. Stat1 was affiliated to the enriched category "response to bacterium" in functional cluster 1 ([Table 3](#pone.0150858.t003){ref-type="table"}) whereas nuclear factor erythroid derived 2 (Nfe2) was also over-expressed in BCG-challenge relative to the Control mice, although the corresponding categories were enriched below the set threshold.

The macrophages network ([Fig 2](#pone.0150858.g002){ref-type="fig"}) included 129 gene nodes and 66% of the genes were over-expressed in BCG-challenged relative to Control (FDR-adjusted P-value \< 0.001). Casitas B-lineage lymphoma (Cbl) was the most connected gene node, linked to 13 other nodes. This gene was over-expressed in BCG-challenged relative to Control mice yet was not affiliated to the functional categories enriched beyond the set threshold. Discs large homolog 4 (Dlg4) and tumor necrosis factor receptor-associated factor 1 (Traf1) were over-expressed genes in BCG-challenged relative to Control mice and each gene was connected to 7 gene nodes. Dlg4 was affiliated to enriched categories including behavior, endocytosis, and structural molecule activity across 3 functional clusters whereas Traf1 was affiliated to enriched categories related to apoptosis across 2 functional clusters ([Table 3](#pone.0150858.t003){ref-type="table"}). Caspase 3 (Casp3) was linked to 5 other gene nodes and was also over-expressed in BCG-challenged relative to Control mice. Casp3 was affiliated to several enriched categories including apoptosis, kinase activities, and cells activation across 6 functional clusters ([Table 3](#pone.0150858.t003){ref-type="table"}).

Transcriptome differences between microglia and macrophages from BCG-challenged mice {#sec015}
------------------------------------------------------------------------------------

The study of transcript isoforms and genes differentially expressed between microglia and macrophages 7 days after BCG challenge offered additional insights into the roles of both cell types after immune challenge ([Table 1](#pone.0150858.t001){ref-type="table"}). Over 9,780 transcript isoforms corresponding to 9,117 genes were differentially expressed between microglia and macrophages in BCG-challenged mice. The genes most differentially expressed between microglia and macrophages from BCG-challenged mice (log~2~(fold change) \> \|6\|, FDR-adjusted P-value \< 2.0 x 10^−4^) are listed in [Table 6](#pone.0150858.t006){ref-type="table"} together with supporting literature review. An extended list of differentially expressed genes between microglia and macrophages is provided in [S5 Table](#pone.0150858.s005){ref-type="supplementary-material"}.

10.1371/journal.pone.0150858.t006

###### Most extreme differentially expressed genes (FDR-adjusted P-value \< 2.0 x 10^−4^) between microglia and macrophages in BCG-challenged mice and supporting literature review.
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  Gene Symbol   NCBI Gene Name                                                                                                     Log~2~(Macrophages/Microglia)   Reference
  ------------- ------------------------------------------------------------------------------------------------------------------ ------------------------------- --------------------------------------------------------------------------
  Col8a1        collagen, type VIII, alpha 1                                                                                       -13.70                          \[[@pone.0150858.ref103]\]
  Kcne2         potassium voltage-gated channel, Isk-related subfamily, gene 2                                                     -13.63                          \[[@pone.0150858.ref104]\]
  Slc38a5       solute carrier family 38, member 5                                                                                 -11.61                          
  Lrrc3         predicted gene 884                                                                                                 -11.49                          \[[@pone.0150858.ref105]\]
  Nav3          neuron navigator 3                                                                                                 -11.27                          \[[@pone.0150858.ref106]\]
  Gm694         predicted gene 694                                                                                                 -11.07                          
  Capn3         calpain 3                                                                                                          -11.06                          \[[@pone.0150858.ref107]\]
  Gpr34         G protein-coupled receptor 34                                                                                      -10.49                          \[[@pone.0150858.ref039],[@pone.0150858.ref105],[@pone.0150858.ref106]\]
  Lrrn1         leucine rich repeat protein 1, neuronal                                                                            -10.30                          \[[@pone.0150858.ref108]\]
  Wwox          WW domain-containing oxidoreductase                                                                                -10.24                          
  Vstm4         V-set and transmembrane domain containing 4                                                                        -10.07                          
  Ecscr         endothelial cell surface expressed chemotaxis and apoptosis regulator                                              -9.95                           \[[@pone.0150858.ref039]\]
  Cenpf         centromere protein F                                                                                               -9.93                           
  Gm10790       predicted gene 10790                                                                                               -9.93                           
  Tspan7        tetraspanin 7                                                                                                      -9.79                           \[[@pone.0150858.ref105]\]
  Epn3          epsin 3                                                                                                            -9.76                           
  Tmem100       transmembrane protein 100                                                                                          -9.73                           \[[@pone.0150858.ref105]\]
  Leprel1       prolyl 3-hydroxylase 2                                                                                             -9.72                           \[[@pone.0150858.ref105]\]
  Ebf3          early B cell factor 3                                                                                              -9.71                           \[[@pone.0150858.ref105]\]
  Rnu11         U11 small nuclear RNA                                                                                              -9.65                           
  Wdr52         cilia and flagella associated protein 44                                                                           -9.60                           
  Olfml3        olfactomedin-like 3                                                                                                -9.60                           \[[@pone.0150858.ref039],[@pone.0150858.ref105]\]
  Trpm3         transient receptor potential cation channel, subfamily M, member 3                                                 -9.58                           
  Fat3          FAT tumor suppressor homolog 3 (Drosophila)                                                                        -9.56                           
  Adcy2         adenylate cyclase 2                                                                                                -9.52                           
  Kcnj13        potassium inwardly-rectifying channel, subfamily J, member 13                                                      -9.48                           
  Gpr56         adhesion G protein-coupled receptor G1                                                                             -9.46                           \[[@pone.0150858.ref039],[@pone.0150858.ref105]\]
  Sema4g        sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G   -9.45                           
  Ecm1          extracellular matrix protein 1                                                                                     6.89                            \[[@pone.0150858.ref039]\]
  F10           coagulation factor X                                                                                               6.90                            
  Spib          Spi-B transcription factor (Spi-1/PU.1 related)                                                                    6.90                            
  Cxcr5         chemokine (C-X-C motif) receptor 5                                                                                 6.98                            \[[@pone.0150858.ref039]\]
  Cxcl3         chemokine (C-X-C motif) ligand 3                                                                                   7.07                            \[[@pone.0150858.ref039]\]
  Flrt3         fibronectin leucine rich transmembrane protein 3                                                                   7.14                            \[[@pone.0150858.ref039]\]
  Selplg        P-selectin glycoprotein ligand 1                                                                                   7.16                            \[[@pone.0150858.ref039]\]
  Cd19          CD19 antigen                                                                                                       7.17                            \[[@pone.0150858.ref039]\]
  Retnla        resistin like alpha                                                                                                7.25                            \[[@pone.0150858.ref039]\]
  Tnfrsf8       tumor necrosis factor receptor superfamily, member 8                                                               7.42                            
  Cd79a         CD79A antigen (immunoglobulin-associated alpha)                                                                    7.49                            
  Mcoln2        mucolipin 2                                                                                                        7.54                            
  Vsig4         V-set and immunoglobulin domain containing 4                                                                       7.55                            
  Fcrla         Fc receptor-like A                                                                                                 7.64                            
  Ms4a1         membrane-spanning 4-domains, subfamily A, member 1                                                                 7.68                            
  Cd163l1       CD163 molecule-like 1                                                                                              7.76                            
  Gjb5          gap junction protein, beta 5                                                                                       7.86                            
  Vmn2r24       vomeronasal 2, receptor 24                                                                                         7.86                            
  Scn4a         sodium channel, voltage-gated, type IV, alpha                                                                      7.88                            
  Il9r          interleukin 9 receptor                                                                                             7.95                            
  Blk           B lymphoid kinase                                                                                                  8.01                            
  F7            coagulation factor VII                                                                                             8.11                            \[[@pone.0150858.ref040]\]
  Fcrl5         Fc receptor-like 5                                                                                                 8.14                            
  Serpinb2      serine (or cysteine) peptidase inhibitor, clade B, member 2                                                        8.21                            \[[@pone.0150858.ref039]\]
  Pou2af1       POU domain, class 2, associating factor 1                                                                          8.44                            
  Ptges         prostaglandin E synthase                                                                                           8.66                            \[[@pone.0150858.ref109]\]
  Cxcl13        chemokine (C-X-C motif) ligand 13                                                                                  9.30                            \[[@pone.0150858.ref039]\]
  Nos2          nitric oxide synthase 2, inducible                                                                                 9.33                            \[[@pone.0150858.ref079]\]
  Cd5l          CD5 antigen-like                                                                                                   9.34                            \[[@pone.0150858.ref039]\]
  Arg1          arginase, liver                                                                                                    10.05                           \[[@pone.0150858.ref110]\]

The list of genes over-expressed in microglia relative to macrophages from BCG-challenged mice confirms the similar molecular mechanisms shared between neurological disorders and response to immune challenge that also share depressive behaviors. Among the differentially expressed genes, collagen type VIII alpha 1 (Col8a1) and potassium voltage-gated channel Isk-related subfamily gene 2 (Kcne2) were over-expressed meanwhile arginase liver (Arg1) and Nos2 were under-expressed in microglia relative to macrophages from BCG-challenged mice. Col8a1 is up-regulated during repair processes in the mouse brain and collagen subunits have been linked to axonal guidance, synaptogenesis and Schwann cell differentiation \[[@pone.0150858.ref111],[@pone.0150858.ref112]\]. Genomic rearrangements involving this gene have been linked to Tourette syndrome, a neuropsychiatric disorder that can encompass depression symptoms \[[@pone.0150858.ref113]\]. In addition to Col8a1, other genes over-expressed in microglia relative to macrophages from BCG-challenged mice have been linked to neuropsychiatric disorders that encompass depression symptoms ([Table 6](#pone.0150858.t006){ref-type="table"}) including: leucine rich repeat protein 1 neuronal (Lrrn1), tetraspanin 7 (Tspan7), early B cell factor 3 (Ebf3), neuron navigator 3 (Nav3), and WW domain-containing oxidoreductase (Wwox). Over-expression of Lrrn1 was linked to autism spectrum disorder and Tourette syndrome \[[@pone.0150858.ref114]\]. Tspan7 was associated with Huntington\'s chorea, fragile X syndrome, and myotonic dystrophy \[[@pone.0150858.ref115]\]. Changes in the expression of Ebf3 was observed in obsessive-compulsive disorder \[[@pone.0150858.ref116]\]. Nav3 and WW domain-containing oxidoreductase (Wwox) have been implicated in Alzheimer\'s disease \[[@pone.0150858.ref117],[@pone.0150858.ref118]\]. Nav3 was also associated with amyotrophic lateral sclerosis, Parkinson׳s disease \[[@pone.0150858.ref118]\], and was up-regulated in microglia compare to macrophages in response to hypoxia after stroke \[[@pone.0150858.ref106]\].

Kcne2 was among the genes over-expressed in microglia compared to macrophages in BCG-challenged mice. Expression of K+ channel genes follows nitric oxide changes after LPS stimulation indicating that K+ channels are involved in microglia activation \[[@pone.0150858.ref104]\]. Also, sialic acid binding Ig-like lectin H (Siglech) is considered a microglia signature gene \[[@pone.0150858.ref105]\] and G protein-coupled receptor 34 (Gpr34) is highly expressed in microglia and regulates the function, morphology, and phagocytosis of microglia during neuroinflammation \[[@pone.0150858.ref119],[@pone.0150858.ref120]\].

Among the genes under-expressed in microglia relative to macrophages from BCG-challenged mice, the enzymes encoded by Arg1 and Nos2 compete for the same substrate: L-arginine \[[@pone.0150858.ref121],[@pone.0150858.ref122]\]. The over-expression of Nos2 in macrophages is controlled by cytokines in response to a pathogen or inflammatory diseases \[[@pone.0150858.ref079]\] and also up-regulation of Nos2 and Arg1 were found in mouse and rat macrophages treated with LPS \[[@pone.0150858.ref123]\]. MicroRNA 155 (Mir155) was also over-expressed in macrophages relative to microglia ([S5 Table](#pone.0150858.s005){ref-type="supplementary-material"}). This microRNA is a crucial regulator of apoptosis and cell fate decisions in BCG-challenged macrophages and over-expression triggers mitogen-activated protein kinases (MAPK) cascades \[[@pone.0150858.ref124]\]. The genes under-expressed in microglia relative to macrophages after BCG challenge offer insights into the molecular mechanisms that are differentially regulated due to their potential negative impact in the brain.

Functional analysis of transcriptomic differences between microglia and macrophages from BCG-challenged mice {#sec016}
------------------------------------------------------------------------------------------------------------

Enriched functional categories offered additional insights into the roles of microglia and macrophages after sickness recovery from a BCG challenge. [Table 7](#pone.0150858.t007){ref-type="table"} summarizes the DAVID clusters of functional categories surpassing Enrichment Score \> 4 and [S6 Table](#pone.0150858.s006){ref-type="supplementary-material"} presents the complete list of categories surpassing Enrichment Score \> 2 and corresponding gene counts. Functional categories encompassing genes differentially expressed between cell types included leukocyte regulation and activation, chemokine and cytokine activities, MAP kinase activity, and apoptosis ([Table 7](#pone.0150858.t007){ref-type="table"}). These results are consistent with reports of enriched categories in LPS-challenged microglia \[[@pone.0150858.ref125]\] and BCG-challenged macrophages \[[@pone.0150858.ref124]\]. Enrichment of apoptosis ([Table 7](#pone.0150858.t007){ref-type="table"}) is associated with the over-expression of Nos2 and Arg1 in macrophages because these genes regulate the production of peroxynitrites that in turn induce apoptosis \[[@pone.0150858.ref126],[@pone.0150858.ref127]\].

10.1371/journal.pone.0150858.t007

###### Most significant clusters (DAVID Enrichment Score ES \> 4) of enriched Gene Ontology (GO) biological processes (BP) and molecular functions (MF) among the transcript isoforms differentially abundant between microglia and macrophages from BCG-challenged mice.
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  GO cluster[^1^](#t007fn001){ref-type="table-fn"}   Terms[^2^](#t007fn002){ref-type="table-fn"}                                                                                              ES
  -------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------- ------
  BP                                                 \~response to wounding\~inflammatory response\~defense response                                                                          8.72
  BP                                                 \~regulation of cell activation\~regulation of leukocyte activation\~positive regulation of immune system process                        6.72
  BP                                                 \~cell migration\~localization of cell\~cell motility                                                                                    6.55
  BP                                                 \~regulation of cytokine production\~regulation of cytokine biosynthetic process\~positive regulation of cytokine biosynthetic process   6.44
  MF,BP                                              \~purine nucleotide binding\~ribonucleotide binding\~purine ribonucleotide binding                                                       6.14
  MF,BP                                              \~taxis\~chemotaxis\~chemokine activity                                                                                                  6.04
  BP                                                 \~cell death\~death\~programmed cell death                                                                                               5.92
  BP                                                 \~regulation of apoptosis\~regulation of programmed cell death\~regulation of cell death                                                 5.53
  BP                                                 \~regulation of cell activation\~regulation of leukocyte activation\~regulation of lymphocyte activation                                 5.26
  BP                                                 \~vasculature development\~blood vessel development\~blood vessel morphogenesis                                                          4.59
  BP                                                 \~hemopoietic or lymphoid organ development\~immune system development\~hemopoiesis                                                      4.59
  BP                                                 \~regulation of cytokine production\~regulation of interferon-gamma production\~positive regulation of cytokine production               4.26
  MF                                                 \~GTP binding\~guanyl ribonucleotide binding\~guanyl nucleotide binding                                                                  4.07

^1^ Each row corresponds to a cluster of Functional Annotation Tool (FAT) GO categories.

^2^ The three GO terms exhibiting most significant enrichment P-value in each cluster are listed, separated by "\~". Additional information in each cluster is provided in [S6 Table](#pone.0150858.s006){ref-type="supplementary-material"}

Enrichment of categories within over- or under-expressed genes in microglia relative to macrophages detected using GSEA offered confirmatory and complementary information. [Table 8](#pone.0150858.t008){ref-type="table"} lists GSEA findings at FDR-adjusted P-value \< 0.01 and including \> 10 transcript isoforms and [S7 Table](#pone.0150858.s007){ref-type="supplementary-material"} includes a more extensive list of categories enriched at FDR-adjusted P-value \< 0.05 and including \> 10 transcript isoforms per category. The enrichment of categories associated with immune response, ribosome and cytokine activity among genes under-expressed in microglia relative to macrophages could be related to the potential detrimental neurological effect of microglia activation \[[@pone.0150858.ref128]\]. Among the enriched categories including genes over-expressed in the microglia, dysregulation of the tight junction pathway has been related to anxiety behaviors and altered signaling in the brain \[[@pone.0150858.ref129]\]. Similarly enriched categories included brain, central and nervous system development categories are consistent with reports of functional signatures in microglia \[[@pone.0150858.ref105]\].

10.1371/journal.pone.0150858.t008

###### Gene Set Enrichment Analysis (GSEA) categories enriched (FDR-adjusted P-value \< 0.01, \> 10 transcript isoforms) among transcript isoforms under-expressed in microglia relative to peripheral macrophages in BCG-challenged mice.
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  Category                                                  NG[^1^](#t008fn001){ref-type="table-fn"}   P-value     FDR[^2^](#t008fn002){ref-type="table-fn"}
  --------------------------------------------------------- ------------------------------------------ ----------- -------------------------------------------
  Adaptive immune response                                  21                                         \<0.1E-05   \<0.1E-05
  Adaptive immune response                                  20                                         \<0.1E-05   \<0.1E-05
  Positive regulation of immune response                    20                                         \<0.1E-05   \<0.1E-05
  Regulation of immune response                             22                                         \<0.1E-05   \<0.1E-05
  Regulation of immune system process                       46                                         \<0.1E-05   1.05E-03
  Chemokine receptor binding                                28                                         \<0.1E-05   1.18E-03
  Positive regulation of immune system process              37                                         \<0.1E-05   1.34E-03
  Positive regulation of response to stimulus               27                                         \<0.1E-05   1.57E-03
  KEGG primary immunodeficiency                             30                                         \<0.1E-05   1.88E-03
  KEGG ribosome                                             81                                         \<0.1E-05   1.90E-03
  Regulation of lymphocyte activation                       28                                         \<0.1E-05   2.07E-03
  Cellular defense response                                 38                                         \<0.1E-05   2.28E-03
  Lymphocyte activation                                     47                                         \<0.1E-05   3.78E-03
  G protein coupled receptor binding                        35                                         \<0.1E-05   4.34E-03
  Chemokine activity                                        27                                         \<0.1E-05   4.62E-03
  Positive regulation of multicellular organismal process   47                                         \<0.1E-05   4.63E-03
  Cytokine activity                                         61                                         \<0.1E-05   6.65E-03
  B cell activation                                         18                                         \<0.1E-05   7.59E-03
  Locomotory behavior                                       61                                         \<0.1E-05   8.08E-03
  Leukocyte activation                                      51                                         \<0.1E-05   8.95E-03
  KEGG hematopoietic cell lineage                           52                                         \<0.1E-05   9.40E-03

^1^ NG: number of genes.

^2^ FDR: adjusted P-value.

Alternative splicing between microglia and macrophages from BCG-challenged mice {#sec017}
-------------------------------------------------------------------------------

Significant evidence of alternative splicing was detected in the comparison between cell types relative to challenge levels. [Table 9](#pone.0150858.t009){ref-type="table"} summarizes genes with at least nine transcript isoforms and at least two differentially expressed (FDR-adjusted P-value \< 0.05) between microglia and macrophages. [S8 Table](#pone.0150858.s008){ref-type="supplementary-material"} lists all genes that match the broader alternative splicing definition of at least one transcript isoform differentially expressed among multiple isoforms.

10.1371/journal.pone.0150858.t009

###### Genes exhibiting an alternative splicing event between microglia and macrophages in BCG-challenged mice including at least nine transcript isoforms and at least two over- or under-expressed (FDR-adjusted P-value \< 0.05) transcript isoforms between cell types.
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  Gene      NCBI Gene Name                                                   Differential Expression        
  --------- ---------------------------------------------------------------- ------------------------- ---- ----
  Macf1     microtubule-actin crosslinking factor 1                          6                         10   15
  Rbm5      RNA binding motif protein 5                                      6                         9    14
  Bag6      BCL2-associated athanogene 6                                     7                         7    13
  Arhgef1   Rho guanine nucleotide exchange factor (GEF) 1                   7                         7    11
  Rbm39     RNA binding motif protein 39                                     6                         7    12
  Gapvd1    GTPase activating protein and VPS9 domains 1                     7                         5    11
  Josd2     Josephin domain containing 2                                     4                         7    10
  Lrrc16a   leucine rich repeat containing 16A                               6                         5    9
  Rnf220    ring finger protein 220                                          2                         8    9
  Gripap1   GRIP1 associated protein 1                                       6                         4    9
  Anapc1    anaphase promoting complex subunit 1                             5                         5    9
  Arhgap4   Rho GTPase activating protein 4                                  2                         8    9
  Hnrnpl    heterogeneous nuclear ribonucleoprotein L                        4                         6    9
  Il15ra    interleukin 15 receptor, alpha chain                             5                         5    9
  Srsf5     serine/arginine-rich splicing factor 5                           3                         7    8
  Ythdc1    YTH domain containing 1                                          3                         6    8
  Brwd1     bromodomain and WD repeat domain containing 1                    4                         5    8
  Rtn4      reticulon 4                                                      4                         5    8
  Sfrs18    PNN interacting serine/arginine-rich                             4                         5    8
  Wdr13     WD repeat domain 13                                              5                         4    8
  Wnk1      WNK lysine deficient protein kinase 1                            5                         4    7
  Ctage5    CTAGE family, member 5                                           3                         6    6
  Hivep3    human immunodeficiency virus type I enhancer binding protein 3   4                         5    5

^1^Over: transcript isoforms over-expressed in microglia.

^2^Under: transcript isoforms under-expressed in microglia.

^3^Non: not differentially expressed transcript isoforms (FDR-adjusted P-value \< 0.05).

Alternative splicing events differentiating cell types were identified in 387 genes including 1,607 transcript isoforms. Confirming our findings, at least 72 of these genes have recorded alternative splicing events in the microglia as described in the database of alternative splicing of brain cells \[[@pone.0150858.ref130]\]. The alternative splicing cassette characterized by the inclusion or exclusion of an exon was the most frequent type of splicing event with 68% of occurrences. Alternative 3′ and alternative 5′ splicing events characterized by alternative usage of a splicing site on the 3′ and 5′ end of an exon, respectively were the second most common and the less common events amounting to 25% and 7% of the transcript isoforms, respectively. Intron retention (the inclusion or exclusion of a segment previously annotated to be an intron); tandem cassette (the inclusion or exclusion of two or more tandem exons); and mutually exclusive exons (the inclusion of one exon in one transcript and inclusion of a different exon in another transcript) were identified in 19%, 13%, and 11% of the 387 genes investigated, respectively. More than one alternative splicing mode was observed in some genes including WNK lysine deficient protein kinase 1 (Wnk1), tripartite motif-containing 33 (Trim33), and SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily c member 2 (Smarcc2). Among the genes exhibiting alternative splicing events in the microglia, several genes have been associated with neurological disorders. Schizophrenia has been associated with microtubule-actin crosslinking factor 1 (Macf1) \[[@pone.0150858.ref131],[@pone.0150858.ref132]\], Wnk1 \[[@pone.0150858.ref131]\], and Fused in sarcoma (Fus) \[[@pone.0150858.ref133]\]. Our results confirm alternative splicing events that are shared between neurological disorders and microglia after immune challenge and both linked to depressive behaviors.

Gene networks of transcriptomic differences between microglia and macrophages from BCG-challenged mice {#sec018}
------------------------------------------------------------------------------------------------------

Additional understanding of the relationship among genes in microglia and macrophages from BCG-challenged mice was gained from networks visualization. A network was depicted considering the 2,487 most extreme differentially expressed genes between microglia and macrophages (log~2~(fold change) \> \|2\|, FDR-adjusted P-value \< 2.0 x 10^−4^). From these, sub-networks connecting more than 5 genes are presented to facilitate visualization and interpretation. A gene network was constructed that included 146 genes with 39% of the genes over-expressed in microglia and the rest under-expressed ([Fig 3](#pone.0150858.g003){ref-type="fig"}). The predominance of genes under-expressed in microglia relative to macrophages suggests that gene dysregulation leading to negative neurological effects is more contained and quickly resolved in microglia than in macrophages after a BCG challenge.

![Network of genes differentially expressed between microglia and macrophages in BCG-challenged mice.\
Red (green) nodes denote genes over- (under-) expressed in BCG-challenged relative to Control mice. All genes were differentially expressed at FDR-adjusted P-value \< 0.0001. Edges denote known relationships between genes in the SysBiomics repository. Framed genes (squares) are discussed in the manuscript.](pone.0150858.g003){#pone.0150858.g003}

Janus kinase (Jak2) was the most connected gene in the network, linked to 11 other genes ([Fig 3](#pone.0150858.g003){ref-type="fig"}). This gene was under-expressed in microglia relative to macrophages and was affiliated to the enriched categories of protein kinase activity, nucleotide binding, apoptosis, cell differentiation, and regulation of phosphorylation in four functional clusters ([Table 7](#pone.0150858.t007){ref-type="table"}). Kit oncogene (Kit) was under-expressed in microglia relative to macrophages, was linked to eight other genes, and was affiliated to the enriched categories cell migration, chemotaxis, nucleotide binding, phosphorylation, protein kinase activity, apoptosis, leukocyte proliferation and differentiation distributed across 11 functional clusters ([Table 7](#pone.0150858.t007){ref-type="table"}). Diaphanous homolog 1 (Diap1) was also under-expressed in microglia, was connected to seven gene nodes, and was affiliated to the functional categories actin cytoskeleton and protein organization that were enriched below the threshold.

The most connected genes over-expressed in microglia relative to macrophages ([Fig 3](#pone.0150858.g003){ref-type="fig"}) included Rous sarcoma oncogene (Src), ubiquitin specific peptidase 2 (Usp2), and transforming growth factor, beta receptor I (Tgfbr1) and these genes were linked to 9, 7, and 5 other genes, respectively. Src is affiliated to enriched categories including cell migration, protein kinase activity, nucleotide binding, apoptosis, and cell adhesion in six clusters ([Table 7](#pone.0150858.t007){ref-type="table"}). Ups2 is affiliated to enriched categories including phosphate and phosphorus metabolic process in one cluster and Tgfbr1 is affiliated to enriched categories including cell migration, nucleotide binding, phosphorylation, protein kinase activity, angiogenesis and apoptosis in seven clusters ([Table 7](#pone.0150858.t007){ref-type="table"}). The genes most connected in the network enriched apoptosis, cell migration, chemotaxis, and cell adhesion categories. This finding is in agreement with reports of the functional response of macrophages \[[@pone.0150858.ref124],[@pone.0150858.ref134]\] and microglia \[[@pone.0150858.ref135]\] after a bacterial challenge.

This research studied the transcriptome of whole-brain microglia. However, microglia from different brain regions is likely to contribute unequally to depressive behaviors. Likewise, some brain regions are more responsive to periphery immune challenges than others. Additional studies that can parse the differential effect of periphery BCG challenge across brain regions and the corresponding changes in the transcriptome will offer more precise insights into the association between the transcriptome changes in response to immune challenge within brain regions and corresponding depressive-like behaviors.

Conclusions {#sec019}
===========

The impact of immune challenge on the microglia after recovery from sickness and the implications on depressive behaviors was studied. The transcriptome of microglia 7 days after BCG challenge was compared to the corresponding transcriptome from unchallenged Control mice and to macrophages from the same mice. The number of genes differentially expressed between BCG-challenged and Control mice suggests the capacity of microglia to restrain or quickly resolve transcriptomic dysregulation relative to macrophages. The differential expression of Kmo in microglia between BCG-challenged and Control mice suggests that Kmo is a potential target of pro-inflammatory cytokines in the kynurenine pathway and a potential factor of depressive-like symptoms that remain after sickness symptoms subside. The over-expression of a number of genes, including Ifng and Il1b, in microglia relative to macrophages offered further evidence of transcriptome conditions associated with depression-like symptoms. Functional analysis highlighted the enrichment of categories including immune response and chemotaxis by genes over-expressed in BCG-challenged compared to Control mice in both cell types. Network visualization uncovered the key role of Jak2, Stat3, Stat1, and Nfe2 as hub genes, dysregulated and connected to other dysregulated genes in the microglia 7 days after BCG challenge.

The large number of differentially expressed genes between cell types from BCG-challenged mice speaks to the response of these cells to immune challenge. Also, a number of genes exhibiting differential splicing events between microglia and macrophages in this study have been linked to neurological disorders. Network visualization depicted the capability of microglia to exhibit transcriptome dysregulation after sickness recovery from immune challenge, albeit lower than macrophages. The present study provides ample evidence that the microglia transcriptome dysregulation after BCG challenge is shared with neurological disorders that also exhibit depressive behaviors.
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